DISC1 Pathway Activators for Neurogenesis in Neural Progenitor Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for neurological and neuropsychiatric disorders, such as schizophrenia and bipolar disorder, are limited due to a lack of understanding of the underlying anatomical or biochemical pathologies, and there is a need for effective methods to promote neurogenesis and treat related disorders.
Innovation Solution
Activating the DISC1 pathway in adult neural progenitor cells using DISC1 pathway activators, such as DISC1 agonists or inducing agents, to enhance proliferation and differentiation, thereby addressing the underlying cellular defects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current therapies are used for neurological disorders, then treatment is provided, but the therapies are limited due to lack of understanding of underlying pathologies
Solution Approach 1:
The patent uses the DISC1 pathway as an intermediary mechanism to connect neural progenitor cell function to neurological disorder pathology. By identifying DISC1 as a key mediator in the Wnt signaling pathway that regulates neural progenitor proliferation and differentiation, the invention provides a molecular bridge between observable symptoms and underlying cellular defects, enabling more effective targeted therapies
2Productivity
If suppression of DISC1 occurs, then cell cycle exit and differentiation are promoted, but neural progenitor proliferation is reduced
Solution Approach 1:
The patent applies parameter changes by modulating DISC1 pathway activity levels to control the balance between neural progenitor proliferation and differentiation. By adjusting the activation state of DISC1 and its interaction with GSK3β and the Wnt pathway, the invention can shift cellular behavior between proliferation and differentiation states, providing temporal and quantitative control over neurogenesis
3Productivity
If DISC1 gain-of-function occurs, then progenitor proliferation is promoted, but premature cell cycle exit is prevented
Solution Approach 1:
The patent implements dynamics by creating a responsive regulatory system where DISC1 pathway activity can adaptively control progenitor cell behavior. The dynamic interaction between DISC1, GSK3β, and the Wnt pathway allows the system to respond to changing physiological conditions, adjusting proliferation rates and differentiation timing to match developmental or pathological needs
Data Source
AI summary
The invention relates to methods of treating neurological disorders in a subject, by activating a DISC1 pathway. Methods of promoting neurogenesis in adult neural progenitor cells, enhancing nerve generation and treating GSK3 disorders as well as related compositions are also provided.